Provided are kinases inhibitors, pharmaceutical compositions comprising such compounds, and methods of using such compounds or compositions, such as methods of treating a proliferation disorder, such as a cancer or a tumor, or in some embodiments disease or disorders related to the dysregulation of kinase such as, but not limited to kinases such as MEK, COT1, FGFR4, MINK, MYO3A, PKG1B, and PLK3.
提供了激酶
抑制剂、包含这些化合物的药物组合物以及使用这些化合物或组合物的方法,例如治疗增殖性疾病的方法,例如癌症或肿瘤,或在某些实施例中与激酶失调相关的疾病或疾病,例如但不限于MEK、COT1、FGFR4、MINK、MYO3A、PKG1B和PLK3等激酶。